Objective: Interstitial lung diseases (ILD) form a diverse group of parenchymal lung disorders. Currently, a multidisciplinary team (MDT) including pulmonologists, radiologists, and pathologists is the gold standard for ILD diagnosis. Recently, additional subtypes of connective tissue disease (CTD)-ILD with autoimmune features were defined, making the rheumatological assessment increasingly important.
View Article and Find Full Text PDFIntroduction: The endobronchial ultrasound (EBUS) examination is the prime choice in patients with unexplained mediastinal lymphadenopathy. We summarize our experience at Meir Medical Center with EBUS in the elderly (over 75 years of age) patients with lung cancer including indications, benefits and risks factors.
Methods: The study included 20 patients over the age of 75, 13 men and 7 women.
Introduction: Non-small cell lung cancer (NSCLC) is the leading global cause of cancer death. While bone metastases (BM) commonly cause morbidity, bone-targeted agent (BTA) use is variable. We investigated the incidence and impact of BM among unselected NSCLC patients.
View Article and Find Full Text PDFBackground: Bone metastases (BM) are common in NSCLC patients. Despite some potential positive effects of bone-targeted therapies, their use in NSCLC is infrequent, which may relate to the overall poor prognosis of advanced lung cancer. We reviewed the literature to evaluate the incidence, consequences and use of bone-targeting agents in lung cancer patients with BM in both the trial and non-trial clinical setting.
View Article and Find Full Text PDFEur J Cardiothorac Surg
August 2010
Objectives: Bronchoscopic balloon dilatation (BBD) has become a valuable tool in the treatment of tracheobronchial stenosis (TBS). The objective of this study was to assess the short- and long-term effects of BBD.
Methods: A retrospective study that included all patients with confirmed, symptomatic stenosis, who underwent BBD between 2002 and 2008.